What 10 Analyst Ratings Have To Say About Vertex Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 10 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. The average price target is $383.1, implying an upside from the current price of $377.4. The current average has increased by 5.73% from the previous average price target of $362.33.
November 07, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have given an average price target of $383.1 for Vertex Pharmaceuticals, implying an upside from the current price.
The average price target given by analysts suggests a potential upside for Vertex Pharmaceuticals. This indicates a positive sentiment towards the stock, which could lead to an increase in its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100